Medlines
Medlines
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know.  Medicine moves fast... So do we!
Oct. 2, 2026

The Future of Cancer Screening and... Horse Therapy?

Key Takeaways

  • Dr. Jennifer Lincoln joins the Medlines team as a new anchor, bringing expert insights alongside Eva Johnson to discuss this week's top medical headlines.
  • An FDA advisory panel recently evaluated a multi-cancer early detection blood test for adults aged 50 and older, deeming it safe while remaining divided on its overall efficacy.
  • A new UCSF comparison study found that both myomectomy and radiofrequency ablation effectively improved uterine fibroid symptoms over a two-year period without a clinically significant advantage separating the two.
  • Recent health trends highlight a notable surge in emergency room visits related to gambling.
  • New research explores the positive impact of animal therapy, specifically how miniature horses can help lift the mood of teenagers.

Friday, October 2, 2026

In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) joins Medlines as a new anchor! She and Eva Johnson cover an FDA advisory panel vote on an early cancer detection blood test for adults 50 and older. The panel called the test safe, then split on whether it works. The agency still has to rule. They also walk through a UCSF comparison of myomectomy and radiofrequency ablation for uterine fibroids. Both treatments improved symptoms over two years, and neither difference reached the study threshold for a clinically important advantage. Plus: new findings on animal therapy, and more.


Coverage Timeline:

(00:00) Intro (02:01) FDA Backs Multi-Cancer Blood Test (05:08) Uterine Fibroids: Surgery vs. Heat Therapy (07:47) Gambling ER Visits Surge (09:01) Miniature Horses Lift Teen Mood


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.


Sources & Media Attributions for Today's Episode Available At:

www.medlinespod.com/sources


Medlines is a Human Content Production

Frequently Asked Questions

Who is the new anchor joining Dr. Jennifer Lincoln on Medlines?

Dr. Jennifer Lincoln joins Eva Johnson as a new anchor on Medlines to cover the latest healthcare headlines.

What did the FDA advisory panel decide about the multi-cancer blood test?

The panel concluded that the early cancer detection blood test for adults 50 and older is safe, but they split on whether it effectively works, leaving the final ruling up to the agency.

How do myomectomy and radiofrequency ablation compare for uterine fibroids?

A UCSF comparison showed that both treatments improved uterine fibroid symptoms over two years, with neither showing a clinically important advantage over the other.